Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model
- 15 July 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 43 (2), 243-248
- https://doi.org/10.1016/0049-3848(86)90066-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinBlood, 1985
- Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin IIICarbohydrate Research, 1984
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparinThrombosis Research, 1981
- ANTITHROMBIN III AND HEPARINBritish Medical Bulletin, 1978